Recent Finacing
Recent Raise
Immunis is a clinical-stage biotechnology company developing stem cell–derived multi-active secretome biologics, including IMM01‑STEM, for age-related muscle atrophy and metabolic dysfunction, currently in Phase 1/2a trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
